Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Japan Tissue Engineering Co., Ltd.
No Price
Closing Price XTKS 28.04.2026:
534,00 JPY
28.04.2026 06:30
Current Prices from Japan Tissue Engineering Co., Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
7774.T
JPY
28.04.2026 06:30
534,00 JPY
-3,00 JPY
-0,56 %
Share Float & Liquidity
Free Float27,21 %
Shares Float11,05 M
Shares Outstanding40,61 M
Company Profile for Japan Tissue Engineering Co., Ltd. Share
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited.
